NRC at a glance
NATIONAL RESEARCH CORP (NRC, SEC CIK 70487) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on August 11, 2026 and Form 4 insider filings as recently as June 25, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), NATIONAL RESEARCH CORP (NRC) reported revenue of $137.4 million (down 4.0% from FY2024) and net income of $11.3 million. Diluted EPS was $50.00.
- As of June 30, 2026, 25 institutional investment managers tracked by SignalX reported holding NATIONAL RESEARCH CORP (NRC) shares worth $109.6 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by HARRISON SHANE R on February 17, 2026 of 8,000 shares at $12.27 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $137.4M
- −4.0% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 25 funds
- $109.6M · +2 vs prior quarter
- Latest 8-K
- Aug 11, 2026
- Item 5.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Revenue $35.4M, up 4% YoY from $34.0M; recurring existing-customer revenue increased $1.2M
- Operating margin (9)% vs 5% YoY; operating loss $3.2M vs $1.6M income
- Adjusted EBITDA margin 27% vs 30% YoY; adjusted EBITDA $9.4M vs $10.3M
- Operating cash flow $1.4M vs $(1.1)M; free cash flow $0.1M vs $(4.1)M
- Cash $3.3M; $7.4M share repurchases and $3.5M quarterly dividend declared; liquidity sufficient for foreseeable needs
Risk Factors
- No Risk Factors section provided in the submitted filing excerpt
- Credit Agreement restrictions on dividends and repurchases tied to fixed-charge coverage and leverage ratios
- Repurchases totaled $7.4 million, reducing remaining authorization to $50,657,850
- No operational, regulatory, legal, competitive, or currency risks disclosed in the provided text
AI summary of the NRC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 5.02: Departure/Appointment of Directors or Principal Officers
- CFO Shane Harrison resigning effective August 28, 2026 to pursue an outside professional opportunity
- CFO transition creates near-term financial leadership and reporting continuity risk
Item 2.02: Results of Operations and Financial Condition
- Q2 fiscal 2026 results for quarter ended June 30, 2026
- Press release furnished as Exhibit 99.1 contains financial and operating results
Item EX-99.1: Item EX-99.1
- Q2 revenue $35.4M, up 4% YoY, while TRCV reached $151.9M, up 11% and signaling stronger contracted revenue visibility
- GAAP net loss $3.3M versus $0.1M loss prior year, driven partly by $7.4M non-cash stock compensation and $3.2M transition costs
Item 5.07: Submission of Matters to a Vote of Security Holders
- All seven director nominees elected for one-year terms through the 2027 annual meeting
- John N. Nunnelly received the weakest support, with 19,218,370 votes for and 796,250 against
Item 5.03: Amendments to Articles of Incorporation or Bylaws
- Stockholders approved governance amendments at the June 23, 2026 annual meeting
- Removed certain supermajority voting requirements, potentially simplifying approval of major corporate actions
AI summaries of NRC 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for NRC
Don't miss the next NRC filing
- Alerts as it files. A push when NRC files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NRC, by share count.
- Ask anything. An AI agent that reads every NRC filing and answers with sources.
NRC alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Berwick Donald M | A | Jun 23, 2026 | 7,697 | - |
| Wheeler Penny Ann | A | Jun 23, 2026 | 7,697 | - |
| NUNNELLY JOHN N | A | Jun 23, 2026 | 7,697 | - |
| Bhandari Parul | A | Jun 23, 2026 | 7,697 | - |
| Lockhart Stephen H | A | Jun 23, 2026 | 7,697 | - |
| Rau Jason Russell | A | Mar 12, 2026 | 60,000 | - |
| HARRISON SHANE R | Buy | Feb 17, 2026 | 8,000 | $12.27 |
| Bhandari Parul | A | Jan 22, 2026 | 8,819 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $143.1M | $137.4M |
| Operating Income | - | $35.2M | $22.6M |
| Net Income | $31.0M | $24.8M | $11.3M |
| Op. Margin | - | 24.6% | 16.4% |
| Net Margin | - | 17.3% | 8.2% |
| Balance Sheet | |||
| Total Assets | $122.4M | $132.5M | $134.9M |
| Equity | - | $31.3M | $14.0M |
| ROE | - | 79.2% | 80.7% |
| Per Share | |||
| EPS | $1.25 | $1.04 | $50.00 |
| Cash Flow | |||
| Operating CF | - | $34.6M | $26.4M |
| CapEx | $15.8M | $15.4M | $10.7M |
Source: XBRL data in NATIONAL RESEARCH CORP (NRC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate NRC share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 25 | $109.6M |
| Q1 2026 | 23 | $86.9M |
| Q4 2025 | 22 | $98.8M |
| Q3 2025 | 25 | $68.9M |
| Q2 2025 | 25 | $94.8M |
| Q1 2025 | 23 | $57.4M |
| Q4 2024 | 18 | $59.4M |
| Q3 2024 | 17 | $54.9M |
- BlackRock+85.5K (+9%)
- Wells Fargo & Co+62.7K (+54%)
- Goldman Sachs Group+14.1K (+17%)
- Vanguard Portfolio Management LLC+11.1K (+16%)
- Citigroup+4.9K (+746%)
- Morgan Stanley−142.6K (-14%)
- AQR Capital Management−49.6K (-29%)
- Bank of America Corp−29.5K (-26%)
- Ameriprise Financial−24.8K (-59%)
- Northern Trust−17.4K (-7%)
- Citadel Advisors LLC+64.1K
- T. Rowe Price Group+9.7K
Source: 13F-HR filings on SEC EDGAR (aggregated from 178 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
NRC filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Aug 11, 2026 | - | Analysis | - |
| 10-Q | Aug 4, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 28, 2026 | - | Analysis | - |
| 8-K | Jun 29, 2026 | - | Analysis | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 4 | Jun 25, 2026 | - | - | - |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Apr 28, 2026 | - | Analysis | - |
| 8-K | Apr 28, 2026 | - | Analysis | - |
| 8-K | Apr 20, 2026 | - | Analysis | - |
| 4 | Mar 13, 2026 | - | - | - |
| 8-K | Mar 5, 2026 | - | Analysis | - |
| 10-K | Mar 5, 2026 | Dec 31, 2025 | - | |
| 4 | Feb 19, 2026 | - | - | |
| 4 | Feb 17, 2026 | - | - | |
| 4 | Feb 17, 2026 | - | - | |
| 8-K | Feb 3, 2026 | - | - | |
| 4 | Jan 26, 2026 | - | - | |
| 4 | Jan 16, 2026 | - | - | |
| 4 | Jan 7, 2026 | - | - | |
| 4 | Dec 17, 2025 | - | - | |
| 10-Q | Nov 7, 2025 | Sep 30, 2025 | Analysis |
Related Health Care companies
- ABSI · Absci CorpServices-Commercial Physical & Biological Research
- CRL · Charles River LaboratoriesServices-Commercial Physical & Biological Research
- INCY · IncyteServices-Commercial Physical & Biological Research
- IQV · IQVIAServices-Commercial Physical & Biological Research
- MXCT · MAXCYTE, INC.Services-Commercial Physical & Biological Research
- OABI · OmniAb, Inc.Services-Commercial Physical & Biological Research
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
NRC SEC filings: frequently asked questions
Which institutions hold NRC stock?
As of June 30, 2026, the largest NATIONAL RESEARCH CORP (NRC) holders among the 13F filers tracked by SignalX were BlackRock ($22.9 million), Morgan Stanley ($18.5 million), Vanguard Capital Management LLC ($14.4 million), Dimensional Fund Advisors ($10.6 million), Renaissance Technologies LLC ($7.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was NRC's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), NATIONAL RESEARCH CORP (NRC) reported revenue of $137.4 million (down 4.0% from FY2024) and net income of $11.3 million. Diluted EPS was $50.00. The figures come from the XBRL data in the 10-K.
What did NRC report in its latest 8-K?
NATIONAL RESEARCH CORP (NRC) filed an 8-K on August 11, 2026 reporting Item 5.02 (Departure/Appointment of Directors or Principal Officers). CFO Shane Harrison resigning effective August 28, 2026 to pursue an outside professional opportunity.
What are the latest NRC SEC filings?
NATIONAL RESEARCH CORP (NRC) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on August 11, 2026 and a Form 4 insider filing on June 25, 2026.
What is NRC's SEC CIK number?
NATIONAL RESEARCH CORP (NRC)'s SEC Central Index Key (CIK) is 70487. EDGAR lists every NRC filing under that number.
Ask anything about NRC
The research agent reads NRC's filings, financials, insider trades and 13F holders, then answers with sources.